106393-80-0
Chemical Structure
ICI 185282
- CAS No.: 106393-80-0
- Formula:C18H21F3O5
- Molecular Weight:374.35
IUPAC Name: (Z)-7-((2R,4R,5S)-4-(2-hydroxyphenyl)-2-(trifluoromethyl)-1,3-dioxan-5-yl)hept-5-enoic acid
InChIKey: ZWAVGFSZMACJHA-ACCWGZECSA-N
SMILES: O=C(O)CCC/C=C\C[C@@H]1[C@H](C2=CC=CC=C2O)O[C@H](C(F)(F)F)OC1
Biological Activity: ICI 185282 is a potent, selective, orally active thromboxane A2 (TXA₂) receptor antagonist. ICI 185282 causes dose-dependent inhibition of U-46619 (HY-108566)-induced platelet aggregation ex-vivo in guinea-pig. ICI 185,282 inhibits bronchospasm induced by U-46619, PGD2 (HY-101988), PGF2α (HY-12956), arachidonic acid (HY-109590), LTD4 and PAF (HY-108635) in vivo. ICI 185282 can be used for bronchial asthma research[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
ICI 185282 | ICI 185282 is a potent, selective, orally active thromboxane A2 (TXA₂) receptor antagonist. ICI 185282 causes dose-dependent inhibition of U-46619 (HY-108566)-induced platelet aggregation ex-vivo in guinea-pig. ICI 185,282 inhibits bronchospasm induced by U-46619, PGD2 (HY-101988), PGF2α (HY-12956), arachidonic acid (HY-109590), LTD4 and PAF (HY-108635) in vivo. ICI 185282 can be used for bronchial asthma research. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
